Antenatal maternal antidepressants drugs affect Activin A concentrations in maternal blood, in amniotic fluid and in fetal cord blood

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue SUPPL. 2, 2011, Pages 32-35

  Bellissima, Valentina ^a   Visser, Gerard H A ^b   Ververs, Tessa F ^b   Bel, Frank Van ^b   Termote, Jacqueline U M ^b   Van Der Heide, Marja ^b   Florio, Pasquale ^c   Li Volti, Giovanni ^d,e   Gazzolo, Diego ^a,e  

^a C Arrigo Children's Hospital   (Italy)

^b Utrecht Medical Center   (Netherlands)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

^e OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

Activin A; Fetal brain; Maternal depression; SSRI; Teratology

Indexed keywords

ACTIVIN A; ANTIDEPRESSANT AGENT; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AMNION FLUID; APGAR SCORE; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; CASE CONTROL STUDY; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; FETUS; FETUS BLOOD; GESTATIONAL AGE; HUMAN; LABORATORY TEST; MALE; MATERNAL BLOOD; PERINATAL DRUG EXPOSURE; PRENATAL PERIOD; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY; UMBILICAL ARTERY; UMBILICAL CORD BLOOD; UMBILICAL VEIN; VAGINAL DELIVERY;

EID: 80053551308     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004;103:698-709. (Pubitemid 40459031)
2. Lattimore KA, Donn SM, Kaciroti N, Kemper AR, Neal CR Jr, Vazquez DM. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis. J Perinatol 2005;25:595-604. (Pubitemid 43118131)
3. Ververs TF, van Wensen K, Freund MW, van der Heide M, Visser GH, Schobben AF, de Jong-van den Berg LT, Egberts AC. Association between antidepressant drug use during pregnancy and child healthcare utilisation. BJOG 2009;116:1568-1577.
4. Austin MP. To treat or not to treat: maternal depression, SSRI use in pregnancy and adverse neonatal effects. Psychol Med 2006;36:1663-1670.
5. Bonari L, Pinto N, Ahn E, Einarson A, Steiner M, Koren G. Perinatal risks of untreated depression during pregnancy. Can J Psychiatry 2004;49:726-735. (Pubitemid 40100521)
6. Costa LG, Steardo L, Cuomo V. Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects. Pharmacol Rev 2004;56:103-147. (Pubitemid 38314581)
7. Louik C, Lin AE, Werler MM, Hernández-Díaz S, Mitchell AA. Firsttrimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 2007;356:2675-2683. (Pubitemid 47001035)
8. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006;354:579-587. (Pubitemid 43209105)
9. Hemels ME, Einarson A, Koren G, Lanctt KL, Einarson TR. Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother 2005;39:803-809. (Pubitemid 40570656)
10. Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005;293:2372-2383. (Pubitemid 40676760)
11. Mulder EJ, Ververs FF, de Heus R, Visser GH. Selective Serotonin Reuptake Inhibitors Affect Neurobehavioral Development in the Human Fetus. Neuropsychopharmacology 2011.
12. Noorlander CW, Ververs FF, Nikkels PG, van Echteld CJ, Visser GH, Smidt MP. Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities. PLoS ONE 2008;3:e2782.
13. Ververs T, Kaasenbrood H, Visser G, Schobben F, de Jong-van den Berg L, Egberts T. Prevalence and patterns of antidepressant drug use during pregnancy. Eur J Clin Pharmacol 2006;62:863-870. (Pubitemid 44521435)
14. Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A, Edwards R. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005;365:482-487. (Pubitemid 40215730)
15. Florio P, Gazzolo D, Luisi S, Petraglia F. Activin A in brain injury. Adv Clin Chem 2007;43:117-130. (Pubitemid 44960962)
16. Gazzolo D, Abella R, Marinoni E, di Iorio R, Li Volti G, Galvano F, Frigiola A, et al. New markers of neonatal neurology. J Matern Fetal Neonatal Med 2009;22 Suppl 3:57-61.
17. Luisi S, Florio P, Reis FM, Petraglia F. Expression and secretion of activin A: possible physiological and clinical implications. Eur J Endocrinol 2001;145:225-236. (Pubitemid 32825654)
18. Florio P, Abella RF, de la Torre T, Giamberti A, Luisi S, Butera G, Cazzaniga A, et al. Perioperative activin A concentrations as a predictive marker of neurologic abnormalities in children after open heart surgery. Clin Chem 2007;53:982-985. (Pubitemid 46744258)
19. Tretter YP, Hertel M, Munz B, ten Bruggencate G, Werner S, Alzheimer C. Induction of activin A is essential for the neuroprotective action of basic fibroblast growth factor in vivo. Nat Med 2000;6:812-815. (Pubitemid 30469432)
20. Florio P, Frigiola A, Battista R, Abdalla Ael H, Gazzolo D, Galleri L, Pinzauti S, et al. Activin A in asphyxiated full-term newborns with hypoxic ischemic encephalopathy. Front Biosci (Elite Ed) 2010;2:36-42.
21. Florio P, Luisi S, Moataza B, Torricelli M, Iman I, Hala M, Hanna A, et al. High urinary concentrations of activin A in asphyxiated full-term newborns with moderate or severe hypoxic ischemic encephalopathy. Clin Chem 2007;53:520-522. (Pubitemid 46463863)
22. Florio P, Luisi S, Bruschettini M, Grutzfeld D, Dobrzanska A, Bruschettini P, Petraglia F, Gazzolo D. Cerebrospinal fluid activin a measurement in asphyxiated full-term newborns predicts hypoxic ischemic encephalopathy. Clin Chem 2004;50:2386-2389. (Pubitemid 39552179)
23. Duman RS. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 2004;5:11-25. (Pubitemid 38391953)
24. Campbell S, Thoms A. Ultrasound measurement of the fetal head to abdomen circumference ratio in the assessment of growth retardation. Br J Obstet Gynaecol 1977;84:165-174. (Pubitemid 8114019)
25. Florio P, Abella R, Marinoni E, Di Iorio R, Li Volti G, Galvano F, Pongiglione G, et al. Biochemical markers of perinatal brain damage. Front Biosci (Schol Ed) 2010;2:47-72.
26. Florio P, Calonaci G, Luisi S, Severi FM, Ignacchiti E, Palumbo M, Bocchi C, Petraglia F. Inhibin A, inhibin B and activin A concentrations in umbilical cord artery and vein. Gynecol Endocrinol 2003;17: 181-185. (Pubitemid 36760718)
27. Florio P, Luisi S, Ciarmela P, Severi FM, Bocchi C, Petraglia F. Inhibins and activins in pregnancy. Mol Cell Endocrinol 2004;225:93-100. (Pubitemid 39297058)
28. Duman RS, Malberg J, Thome J. Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 1999;46:1181-1191. (Pubitemid 30114436)
29. Manji HK, Duman RS. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull 2001;35:5-49.
30. Petraglia F, Gomez R, Luisi S, Florio P, Tolosa JE, Stomati M, Romero R. Increased midtrimester amniotic fluid activin A: a risk factor for subsequent fetal death. Am J Obstet Gynecol 1999;180: 194-197. (Pubitemid 29088414)
31. Florio P, Perrone S, Luisi S, Vezzosi P, Longini M, Marzocchi B, Petraglia F, Buonocore G. Increased plasma concentrations of activin a predict intraventricular hemorrhage in preterm newborns. Clin Chem 2006;52:1516-1521. (Pubitemid 44148314)